Glutathione Dosage Guide
Oral liposomal, IV, intranasal, and topical protocols with evidence-based ranges, cycling, and safety notes.
In This Guide
What Is Glutathione?
Glutathione is a three-amino-acid peptide, made from glutamate, cysteine, and glycine, that every cell in the body builds for itself. It is the most abundant antioxidant inside human cells. It neutralizes unstable molecules called free radicals, serves as a cofactor for several detoxification enzymes, and maintains the redox balance that mitochondria need to produce energy efficiently.
Unlike most peptides profiled on PeptideWiki, glutathione is endogenously produced and widely sold as a dietary supplement. Research interest spans five main application areas: aging and mitochondrial health, immune function, neurodegenerative disease, liver detoxification, and dermatology. The evidence base includes a Phase 3 trial in chemotherapy-induced neuropathy and multiple Phase 1 and Phase 2 trials in healthy adults, Parkinson's disease, and cosmetic skin applications.
Use our Peptide Dosage Calculator if you are calculating injectable volumes from a compounded vial. For oral liposomal and capsule forms, product labels list dose per serving directly.
Key Characteristics:
- Tripeptide structure – Built from three amino acids (glutamate, cysteine, glycine), joined by unusual gamma-peptide bonds that resist some digestive enzymes.
- Endogenous production – Every cell synthesizes its own glutathione using an ATP-dependent two-step process. Liver concentrations are the highest in the body.
- Declines with age – Intracellular glutathione falls with age and chronic illness. Low levels are linked to oxidative stress and mitochondrial dysfunction.
- Many administration forms – Oral capsule, oral liposomal liquid, sublingual, S-acetyl, intravenous, intramuscular, subcutaneous, intranasal, nebulized, and topical forms are all used clinically.
- Phase 3 clinical evidence – A 195-patient Phase 3 trial evaluated IV glutathione for chemotherapy-induced peripheral neuropathy. Multiple Phase 1 and Phase 2 trials cover other indications.
- Not approved as a drug – Sold over the counter as a dietary supplement in the United States. IV, IM, and intranasal forms are available by prescription through compounding pharmacies.
For the complete mechanism of action and referenced research, see our full Glutathione profile. New to peptide supplementation? Start with the Beginner's Guide to Peptides.
How Glutathione Dosage Is Determined
Glutathione dosing sits at an unusual intersection of published clinical trial data, established compounding pharmacy protocols, and manufacturer-funded supplement research. Because glutathione is endogenous and widely studied, dose selection leans more heavily on human trial data than on animal studies and allometric scaling.
Published Clinical Trials
The Penn State group ran a 61-adult randomized trial (NCT01044277) at 125 mg and 500 mg twice daily for six months, showing dose-dependent increases in blood glutathione stores. A 124-person follow-up trial at the University of Florida (NCT02438956) used 500 mg once daily for 120 days and reported improved immune cell function and fewer cold symptoms in older adults. The liposomal form has the strongest per-dose biomarker evidence: a pilot in 12 healthy adults showed whole blood glutathione rising 40 percent within two weeks at 500 mg per day.
The Precursor Approach (GlyNAC)
A separate research line led by the Sekhar laboratory at Baylor College of Medicine uses glycine plus N-acetylcysteine (GlyNAC) as precursor loading rather than direct glutathione supplementation. A placebo-controlled randomized trial of 24 older adults ran for 16 weeks and corrected intracellular glutathione deficiency, oxidative stress, mitochondrial dysfunction, insulin resistance, and several physical function measures. This approach uses higher total mass (grams per day of glycine plus NAC) but may produce larger intracellular glutathione gains than oral glutathione alone.
IV Dosing Precedent
The Hauser IV pilot in Parkinson's disease (21 patients) used 1,400 mg three times weekly for four weeks. This dose became the de facto reference for functional medicine IV protocols. Clinic practice typically uses 600 to 1,200 mg per session for general detox and 1,400 to 2,400 mg for intensive chronic illness protocols.
Common Consumer Dose
The most commonly sold consumer dose for oral liposomal glutathione is 500 mg per day, which matches the dose used in the two largest published trials in healthy adults: NCT01044277 at Penn State Hershey (61 adults, 500 mg twice daily for 6 months) and NCT02438956 at the University of Florida (124 adults, 500 mg once daily for 120 days using Setria). Clinical-grade product labels typically recommend starting at 100 to 250 mg per day for 1 to 2 weeks to check tolerance, then moving to 500 mg. Higher doses (1,000 mg or more per day) appear in published trials only under practitioner direction for specific clinical goals such as chemotherapy neuropathy prevention.
Standard Glutathione Dosage Ranges
Glutathione is dosed very differently across forms. The tables below reflect published trial protocols and established compounding pharmacy ranges. Always start at the lower end for your chosen form.
Oral Liposomal (Most Common Consumer Form)
| Level | Dose | Frequency | Notes |
|---|---|---|---|
| Low / Starter | 100–250 mg | 1x daily | 1–2 weeks to assess tolerance |
| Standard | 500 mg | 1x daily | Dose used in most published trials |
| Aggressive / Advanced | 500–1,000 mg | 2x daily | Chronic illness protocols, practitioner-directed only |
Intravenous (Clinic)
| Level | Dose | Frequency | Notes |
|---|---|---|---|
| General wellness | 600–1,200 mg | 1–2x weekly | 4–8 week course typical |
| Parkinson's research dose | 1,400 mg | 3x weekly | 4 weeks (Hauser 2009 protocol) |
| Intensive detox | 1,400–2,400 mg | 1–2x weekly | 8–12 week course, practitioner-directed |
Intramuscular and Subcutaneous
| Route | Dose | Frequency | Notes |
|---|---|---|---|
| IM | 200 mg (1 mL at 200 mg/mL) | 1–2x weekly | Site rotation: deltoid, glute, quadriceps |
| SC | 100 mg (0.5 mL at 200 mg/mL) | Every 48 hours | Abdomen or thigh |
Intranasal (Research Protocol)
| Concentration | Dose per Spray | Frequency | Notes |
|---|---|---|---|
| 100 mg/mL | 100 mg per nostril | 3x daily | Bastyr Phase 1 PD protocol low dose |
| 200 mg/mL | 200 mg per nostril | 3x daily | Bastyr Phase 1 PD protocol high dose |
Topical
| Form | Concentration | Frequency | Notes |
|---|---|---|---|
| Oxidized glutathione (GSSG) lotion | 2% | 2x daily | 10-week trial in women (PMID 25378941) |
| Reduced glutathione (GSH) cream | 1–2% | 2x daily | Variable in commercial products |
Calculate Your Glutathione Dose
For oral liposomal and capsule forms, the dose per serving is printed on the label and no math is needed. For compounded injectable and intranasal forms, the calculation is a straightforward volume conversion from the compounding pharmacy's listed concentration.
Oral Liposomal – Common Brand Reference
| Form | Per Serving | For 500 mg/day | For 1,000 mg/day |
|---|---|---|---|
| Liquid pump (100 mg / 2 pumps) | 100 mg | 10 pumps (5 servings) | 20 pumps (10 servings) |
| Liquid (250 mg / tsp) | 250 mg | 2 tsp | 4 tsp |
| Capsule (500 mg) | 500 mg | 1 capsule | 2 capsules |
Injectable – Volume From a Compounded Vial
Worked Example:
- Compounded concentration: 200 mg per mL (standard for IM/SC)
- Target dose: 200 mg
- Volume to draw: 200 mg ÷ 200 mg/mL = 1 mL (100 units on a 1 mL insulin syringe)
For a 100 mg dose (0.5 mL at 200 mg/mL), that is 50 units on a 1 mL insulin syringe. Confirm your syringe scale matches the unit count printed.
Quick Reference – 200 mg/mL Compounded Vial
| Target Dose | Volume | Units (1 mL syringe) | Typical Route |
|---|---|---|---|
| 100 mg | 0.5 mL | 50 units | SC every 48 hours |
| 200 mg | 1.0 mL | 100 units | IM weekly |
| 400 mg | 2.0 mL | Use 3 mL syringe | IM, split between two sites |
Skip the Math – Use Our
Enter your vial size, water volume, and desired dose for instant calculations with zero manual math.
Forms and Preparation
Glutathione is sold in more distinct forms than almost any other peptide. Preparation varies by route: liposomal products arrive ready-to-use, IV and IM compounded vials are already in solution, and topical creams are pre-formulated. Unlike BPC-157 or TB-500, glutathione is not typically reconstituted from lyophilized powder by consumers.
Supplies Needed by Form:
- Oral liposomal: bottle with pump or teaspoon; refrigerator; empty-stomach timing
- Oral capsule / S-acetyl: standard capsule storage; water
- IV: licensed clinic administration; no home preparation
- IM / SC: compounded preservative-free vial (typically 200 mg per mL); insulin syringe (29-31 gauge); alcohol swabs
- Intranasal: compounded nasal spray bottle (100 or 200 mg per mL, preservative-free)
- Topical: pre-formulated cream or lotion; clean dry skin
Preparation Steps by Form
Select the Form for Your Goal
Oral liposomal (500 to 1,000 mg per day) is the default for general antioxidant support, longevity, and immune function. IV (600 to 1,400 mg per session, 1 to 3 times per week) is used for detox protocols, Parkinson's research, and chemotherapy neuropathy prevention. Intranasal (300 to 600 mg per day) is used for neurodegenerative research. Topical (2 percent oxidized glutathione) is used for skin applications.
Oral Liposomal: Check Storage Requirements
Most clinical-grade liposomal products (Quicksilver Scientific, Core Med Science, Tri-Fortify) arrive as liquid and must be refrigerated. Use within 30 days of opening. Some brands recommend freezer storage of unopened bottles. Capsule and S-acetyl forms are generally room-temperature stable.
Oral: Take on an Empty Stomach
Take liposomal liquid or capsules at least 10 minutes before a meal. For liposomal liquids, hold the dose in the mouth for 30 to 90 seconds before swallowing. This brief sublingual exposure has been shown in a pilot study to meaningfully raise blood glutathione markers within 5 to 30 minutes.
IV and IM: Source from a Licensed Compounding Pharmacy
Compounded glutathione is supplied as preservative-free solution, typically 200 mg per mL. Administered by a licensed practitioner via IV push (10 to 20 minutes for doses of 600 to 1,400 mg) or IM injection (200 mg over 1 mL, 1 to 2 times per week). Never use IV glutathione from unregulated med-spa or cosmetic sources.
Intranasal: Use Compounded Preservative-Free Spray
Intranasal glutathione is typically compounded as 100 to 200 mg per mL preservative-free nasal spray. The published Phase 1 Parkinson's protocol used 1 mL (100 or 200 mg) per nostril three times daily. Screen for chronic sinusitis before starting.
Topical: Apply to Clean Skin
Topical 2 percent oxidized glutathione (GSSG) lotion or 1 to 2 percent GSH cream is applied to clean, dry skin twice daily. Most published protocols run 10 to 12 weeks for skin-brightening endpoints. Spot-test on a small area for 48 hours before broader application if you have sensitive skin.
Storage
- Oral liposomal (liquid): Refrigerate at 2–8°C after opening. Use within 30 days. Some brands recommend freezer storage before first opening.
- Oral capsule and S-acetyl: Room-temperature storage; check manufacturer expiration date.
- Compounded IV / IM / SC solution: Refrigerate per pharmacy instructions; protect from light.
- Intranasal spray: Refrigerate or room-temperature per pharmacy instructions; typically 28–30 day in-use limit.
- Topical: Per product label; typically cool, dry place away from direct sunlight.
For a visual walkthrough of injection technique if you are self-administering IM or SC, see our How to Reconstitute Peptides guide (the injection mechanics are the same even though glutathione does not require reconstitution).
Glutathione Dosage by Goal
Different goals call for different forms, doses, and durations. The table below maps common goals to published trial doses or established compounding pharmacy ranges.
| Goal | Form | Dose | Frequency | Duration |
|---|---|---|---|---|
| General antioxidant / longevity | Oral liposomal | 500 mg | Daily | Ongoing maintenance |
| Immune support (older adults) | Oral (Setria) | 500 mg | Daily | 120+ days |
| Age-related GSH deficiency (precursor loading) | GlyNAC oral | ~100 mg/kg glycine + ~100 mg/kg NAC per day | Divided BID | 16–24 weeks |
| Detox / chronic illness support | IV | 600–1,400 mg | 1–2x weekly | 4–8 weeks |
| Parkinson's research protocol | IV or intranasal | 1,400 mg IV or 300–600 mg intranasal | 3x weekly (IV); TID (intranasal) | 4–12 weeks |
| Chemo-induced neuropathy prevention | IV (oncologist-directed) | Per protocol (pre-paclitaxel) | Before each chemo cycle | Duration of chemo regimen |
| Skin brightening (sun-exposed areas) | Oral or topical | 500 mg oral or 2% GSSG topical | Daily | 10–12 weeks |
Glutathione Administration Guide
Each form has its own correct technique. This section covers the five most common routes.
Oral Liposomal (Most Common)
- Take on an empty stomach, at least 10 minutes before food or other supplements.
- For liquid formulations, dispense the dose into the mouth and hold under the tongue for 30 to 90 seconds before swallowing. This brief sublingual contact raises blood glutathione markers acutely.
- For capsules, take with a small sip of water on an empty stomach.
- Typical timing: first dose in the morning. Split dosing (AM and early afternoon) is used for 1,000 mg per day protocols.
Intravenous (Clinic Only)
- Administered only in a licensed clinic by a qualified practitioner.
- Typical technique: slow IV push over 10 to 20 minutes via a 22 or 20 gauge catheter, followed by a sterile saline flush.
- Pre-infusion: blood pressure and heart rate check. Patients with asthma or known sulfite sensitivity are screened before the first dose.
- Do not push glutathione through the same line as IV vitamin C. The two are redox-incompatible during simultaneous infusion.
Intramuscular and Subcutaneous (Home Injection)
- Use a 29 to 31 gauge insulin syringe. For IM, a 25 gauge 1-inch needle is sometimes used.
- IM sites: deltoid (upper arm), ventrogluteal (hip), or vastus lateralis (thigh). Rotate weekly.
- SC sites: lower abdomen (avoid 2-inch radius around the navel) or outer thigh. Pinch the skin and insert at 90 degrees for a standard SC injection.
- Swab the site with an alcohol pad, let dry for 10 seconds, inject, then apply light pressure with a clean gauze or swab.
- Discard used needles in a sharps container.
Intranasal
- Blow the nose gently before use to clear passages.
- Shake the bottle if the label directs. Tilt head slightly forward.
- Insert the nozzle into one nostril, pinch the other shut, and spray while inhaling gently. Repeat on the other side.
- Avoid forceful sniffing, which deposits the spray in the throat rather than the upper nasal tissue where absorption happens.
- Wait 30 seconds between applications. The Bastyr Phase 1 Parkinson's protocol used three administrations per day.
Topical
- Apply to clean, dry skin. Most trial protocols apply twice daily, morning and evening.
- Use a thin layer. More product does not increase absorption and is often washed off or absorbed into clothing.
- For skin-brightening protocols, combine with daily broad-spectrum sunscreen during the day. Most published trials measured changes in sun-exposed areas.
Glutathione Cycle Duration
Unlike injectable peptides where fixed loading and maintenance cycles are standard, glutathione can be taken continuously for extended periods. In the GlyNAC pilot, however, benefits declined after 12 weeks of stopping, so continuous use is the typical pattern.
Loading Phase
A typical loading phase is 4 to 12 weeks of daily oral liposomal dosing (500 mg per day) or 1 to 3 IV sessions per week for 4 to 8 weeks. The goal is to normalize intracellular glutathione to a functional range.
Maintenance Phase
After loading, many protocols reduce to 3 to 5 oral doses per week or a monthly IV session. Some clinicians transition patients entirely to daily oral liposomal as maintenance.
When to Pause or Stop
- Persistent GI issues (loose stools, gas) that do not resolve after a 1-week dose reduction.
- Unresolved sulfur taste or body odor that affects quality of life.
- Starting a chemotherapy regimen that relies on oxidative stress (discuss with oncologist).
- Pregnancy or breastfeeding: not studied in trials, so glutathione is typically paused.
- Any signs of hypersensitivity: rash, hives, swelling, respiratory symptoms.
Measuring Whether It Is Working
Functional medicine clinicians sometimes track whole-blood or intracellular glutathione via specialty labs (Doctor's Data, Genova Diagnostics, and others). The GSH to GSSG ratio is a related redox biomarker. Baseline and 12-week repeats can document whether supplementation is actually changing intracellular stores.
Glutathione Stacking Protocols
Three stacking patterns have the most published support. Each addresses a different mechanistic angle.
Stack 1: GlyNAC (Glycine + N-Acetylcysteine)
The Sekhar lab at Baylor published two trials (pilot and placebo-controlled RCT) showing that glycine plus N-acetylcysteine corrects intracellular glutathione deficiency more reliably than direct glutathione supplementation in older adults. Glycine and NAC are the precursors the cell needs to build glutathione itself. The RCT used approximately 100 mg per kg per day of each amino acid, split into two daily doses, for 16 weeks.
Stack 2: Glutathione + Alpha Lipoic Acid
Alpha lipoic acid (ALA) recycles oxidized glutathione (GSSG) back to the reduced active form (GSH). A typical stack is 500 mg oral liposomal glutathione plus 300 to 600 mg ALA per day. The rationale is to keep a higher proportion of the glutathione pool in the active reduced state.
Stack 3: Glutathione + Vitamin C (Spaced)
Vitamin C supports glutathione recycling and has its own antioxidant activity. Oral glutathione and oral vitamin C can be taken together. IV glutathione and IV vitamin C should be spaced by at least several hours and never pushed through the same line, due to redox incompatibility in solution.
Stack 4: Glutathione + Selenium
Selenium is a cofactor for glutathione peroxidase, the enzyme that uses glutathione to neutralize hydrogen peroxide. Ensuring adequate selenium status (typically 100 to 200 mcg per day from diet plus supplementation if needed) supports the full antioxidant cascade. Do not exceed 400 mcg per day of selenium long-term.
Glutathione Safety and Side Effects
Glutathione is generally well tolerated when used in established forms and doses. Risk is tightly tied to the route and the source, not to the molecule itself.
Common Side Effects
- Mild GI discomfort (gas, loose stools) at doses above 500 mg per day orally
- Transient sulfur taste in the mouth or body odor (normal for sulfur-containing molecules)
- Headache or fatigue during the first 1 to 2 weeks of supplementation
Less Common
- Injection site redness or swelling with IM or SC administration
- Mild sinus irritation with intranasal use
- Skin irritation with topical application (rare)
- Transient flushing during IV administration
Rare but Serious (IV Only)
Severe adverse events have been reported specifically with IV glutathione obtained from unregulated cosmetic clinics, primarily in Southeast Asia for skin-lightening use. Reported events include Stevens-Johnson syndrome, toxic epidermal necrolysis, renal failure, and severe hypersensitivity reactions. The Philippines FDA issued a specific advisory against IV glutathione for skin lightening for this reason.
Contraindications and Cautions
- Active chemotherapy: Do not supplement without oncologist supervision. Some regimens rely on oxidative stress.
- Sulfite-sensitive asthma: Bronchospasm has been reported with nebulized glutathione. Screen before starting nebulized or IV routes.
- Pregnancy and breastfeeding: Not studied in clinical trials. Glutathione is typically paused.
- Unregulated IV sources: Do not use IV glutathione from med-spas, cosmetic clinics without medical licensure, or overseas sources. Use a licensed practitioner with pharmaceutical-grade compounded product.
Stop Use Immediately If
- Signs of allergic reaction: rash, hives, facial or throat swelling
- Severe hypotension, flushing, or dizziness during IV administration
- Persistent chest tightness or bronchospasm with nebulized forms
- Unusual fatigue or jaundice that does not resolve with discontinuation
Common Mistakes
Frequently Asked Questions
Next Steps
Calculate Your Dose
Use our free calculator to get exact syringe volumes for injectable glutathione from a compounded vial.
Open CalculatorView Glutathione Profile
Full peptide profile with mechanism, referenced research studies, and safety details.
View ProfileBrowse All Dosage Guides
Evidence-based dosing protocols for 50+ research peptides.
Browse GuidesVerified sources for Glutathione
These vendors are vetted by PeptideWiki for purity testing and COA transparency.
